These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8580565

  • 1. Calcitonin-like polypeptides without apparent biological activity in a patient with recurrent medullary thyroid carcinoma.
    Nakajima K, Jinkawa I, Hirota T, Ikeda T, Tugawa M, Minami Y, Hanada M.
    Intern Med; 1995 Sep; 34(9):896-900. PubMed ID: 8580565
    [Abstract] [Full Text] [Related]

  • 2. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW, Broelsch CE.
    Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
    [Abstract] [Full Text] [Related]

  • 3. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
    Bojunga J, Dragan C, Schumm-Draeger PM, Usadel KH, Kusterer K.
    Br J Cancer; 2001 Nov 16; 85(10):1546-50. PubMed ID: 11720443
    [Abstract] [Full Text] [Related]

  • 4. Serum calcitonin-negative medullary thyroid carcinoma: role of CgA and CEA as complementary markers.
    Giovanella L, Crippa S, Cariani L.
    Int J Biol Markers; 2008 Nov 16; 23(2):129-31. PubMed ID: 18629788
    [Abstract] [Full Text] [Related]

  • 5. 68Ga-DOTANOC and 18F-FDG PET/CT in metastatic medullary thyroid carcinoma: novel correlations with tumoral biomarkers.
    Souteiro P, Gouveia P, Ferreira G, Belo S, Costa C, Carvalho D, Duarte H, Sampaio IL.
    Endocrine; 2019 May 16; 64(2):322-329. PubMed ID: 30684230
    [Abstract] [Full Text] [Related]

  • 6. Genetic analysis of a hereditary medullary thyroid carcinoma case with normal preoperative serum calcitonin levels.
    Zhang G, Jiang Y, Zhang S, Zhao L, Fan J, Zhang Z, Ma J, Chen R, Xu Y.
    Pathol Res Pract; 2019 Oct 16; 215(10):152529. PubMed ID: 31409511
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potential absence of prognostic implications of severe preoperative hypercalcitoninemia in medullary thyroid carcinoma.
    Zangeneh F, Gharib H, Goellner JR, Kao PC.
    Endocr Pract; 2003 Oct 16; 9(4):284-9. PubMed ID: 14561572
    [Abstract] [Full Text] [Related]

  • 9. Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
    Hajje G, Borget I, Leboulleux S, Chougnet C, Al Ghuzlan A, Mirghani H, Caramella C, Hartl D, Schlumberger M, Baudin E.
    Eur J Endocrinol; 2013 Feb 16; 168(2):113-8. PubMed ID: 23093698
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Diez JJ, Iglesias P.
    Thyroid; 2004 Nov 16; 14(11):984-5. PubMed ID: 15678599
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
    Barbet J, Campion L, Kraeber-Bodéré F, Chatal JF, GTE Study Group.
    J Clin Endocrinol Metab; 2005 Nov 16; 90(11):6077-84. PubMed ID: 16091497
    [Abstract] [Full Text] [Related]

  • 13. [The routine immunohistochemical diagnosis and surgical treatment of medullary carcinoma of the thyroid].
    Gavrailov M, Petkov R, Mladenov B, Todorov G, Kŭtev N.
    Khirurgiia (Sofiia); 1995 Nov 16; 48(2):17-9. PubMed ID: 8531439
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin analogs in the treatment of medullary thyroid carcinoma.
    Díez JJ, Iglesias P.
    J Endocrinol Invest; 2002 Oct 16; 25(9):773-8. PubMed ID: 12398235
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff.
    Romero-Lluch AR, Cuenca-Cuenca JI, Guerrero-Vázquez R, Martínez-Ortega AJ, Tirado-Hospital JL, Borrego-Dorado I, Navarro-González E.
    Eur J Nucl Med Mol Imaging; 2017 Nov 16; 44(12):2004-2013. PubMed ID: 28646462
    [Abstract] [Full Text] [Related]

  • 16. Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.
    Ide A, Ashizawa K, Ishikawa N, Ishii R, Ando T, Abe Y, Sera N, Usa T, Tominaga T, Ejima E, Nakashima M, Ito K, Ito K, Eguchi K.
    Thyroid; 2001 Nov 16; 11(11):1055-61. PubMed ID: 11762716
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K, Kaznowski J, Klimowicz A, Maciejewski A, Łapińska-Cwojdzińska D, Gurgul E, Car AD, Fichna M, Gut P, Gryczyńska M, Ruchała M.
    Endokrynol Pol; 2017 Nov 16; 68(4):434-437. PubMed ID: 28585679
    [Abstract] [Full Text] [Related]

  • 18. Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas?
    Franke WG, Pinkert J, Runge R, Bredow J, Wunderlich G, Koch R.
    Anticancer Res; 2000 Nov 16; 20(6D):5257-60. PubMed ID: 11326706
    [Abstract] [Full Text] [Related]

  • 19. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
    Papapetrou PD, Polymeris A.
    Exp Clin Endocrinol Diabetes; 2012 Mar 16; 120(3):164-8. PubMed ID: 22328112
    [Abstract] [Full Text] [Related]

  • 20. The role of radiotherapy in the management of elevated calcitonin after surgery for medullary thyroid cancer.
    Fersht N, Vini L, A'Hern R, Harmer C.
    Thyroid; 2001 Dec 16; 11(12):1161-8. PubMed ID: 12186504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.